Selective regulation of Bcl-X(L) by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies

Genes and Development

Volumn 12, Issue 16, 1998, Pages 2475-2487

  Packham, Graham ^a,b   White, Elsie L ^c   Eischen, Christine M ^c   Yang, Hui ^c   Parganas, Evan ^c   Ihle, James N ^c,d   Grillot, Didier A M ^e   Zambetti, Gerard P ^c   Nuñez, Gabriel ^e   Cleveland, John L ^c,d  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; Bcl X(L); Jak kinase; Leukemia

Indexed keywords

CYTOKINE RECEPTOR; ERYTHROPOIETIN; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROTECTION; GENE EXPRESSION REGULATION; MOUSE; MYELOID LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTE; SIGNAL TRANSDUCTION; T CELL LEUKEMIA;

ANIMALIA; MURINAE;

EID: 0032529166     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.12.16.2475     Document Type: Article

References (67)

1. Askew, D.S., R.A. Ashmun, B.C. Simmons, and J.L. Cleveland. 1991. Constitutive c-myc expression in an IL-3 dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6: 1915-1922.
2. Askew, D.S., C. Bartholomew, and J.N. Ihle. 1993. Insertional mutagenesis and the transformation of hematopoietic stem cells. Hematol. Pathol. 7: 1-22.
3. H on chromosome 14 and near a transcriptional unit on 18. Cell 41: 889-906.
4. Boise, L.H., M. González-García, C.E. Postema, L. Ding, T. Lindsten, L.A. Turka, X. Mao, G. Nuñez, and C. B. Thompson. 1993. Bcl-X, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597-607.
5. Brimmell, M., R. Mendiola, J. Mangion, and G. Packham. 1998. Bax frameshift mutations in cell lines derived from hemopoietic malignancies are associated with resistance to apoptosis and microsatellite instability. Oncogene 16: 1803-1812.
6. Broome, H.E., C.M. Dargan, S. Krajewski, and J.C. Reed. 1995. Expression of Bcl-2, Bcl-X and Bax after T cell activation and IL-2 withdrawal. J. Immunol. 155: 2311-2317.
7. Canman, C.E., T.M. Gilmer, S.B. Coutts, and M.B. Kastan. 1995. Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes & Dev. 9: 600-611.
8. Cheng, E.H.Y., D.G. Kirsch, R.J. Clem, R. Ravi, M.B. Kastan, A. Bedi, K. Ueno, and J.M. Hardwick. 1997. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 278: 1966-1968.
9. Cleary, M. and J. Sklar. 1985. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint cluster region near a transcriptionally active locus on chromosome 18. Proc. Natl. Acad. Sci. 82: 7439-7443.
10. L through caspase interaction. Proc. Natl. Acad. Sci. 95: 554-559.
11. Cleveland, J.L., J. Troppmair, G. Packham, D.S Askew, P. Lloyd, M. González-García, G. Nuñez, J.N. Ihle, and U.R. Rapp. 1994. v-raf suppresses apoptosis and promotes growth of Interleukin-3-dependent myeloid cells. Oncogene 9: 2217-2226.
12. Damen, J.E., R.L. Cutler, J. Jiao, T. Yi, and G. Krystal. 1995. Phosphorylation of tyrosine 503 in the erythropoietin receptor (EpR) is essential for binding P85 subunit of phosphatidylinositol (PI) 3′-kinase and for EpR-associated PI 3-kinase activity. J. Biol. Chem. 270: 23402-23408.
13. Datta, S.R., H. Dudek, X. Tao, S. Masters, H.A. Fu, Y. Gotoh, and M.E. Grennberg. 1997. Akt phosphorylation of Bad couples survival signals to the cell-intrinsic death machinery. Cell 91: 231-241.
14. Dean, M.D., J.L. Cleveland, U.R. Rapp, and J.N. Ihle. 1987. Role of myc in the abrogation of IL-3 dependence of myeloid FDC-P1 cells. Oncogene Res. 1: 279-296.
15. Delpeso, L., M. González-Garcia, C. Page, R. Herrera, and G. Nuñez. 1997. Interleukin-3-induced phosphorylation of Bad through the protein kinase Akt. Science 278: 687-689.
16. Dudek, H., S.R. Data, T.F. Franke, M.L. Birnbaum, R.J. Yao, G.M. Cooper, R.A. Segal, D.R. Kaplan, and M.E. Greenberg. 1997. Regulation of neuronal survival by the serme-threonine protein kinase Akt. Science 275: 661-665.
17. L. Am. J. Path. 149: 795-803.
18. Franke, T.F., S.I. Yang, T.O. Chan, K. Datta, A. Kazlauskas, D.K. Morrison, D.R. Kaplan, and P.N. Tschlis. 1995. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81: 727-736.
19. Fukada, T., M. Hibi, Y. Yamanaka, M. Takahashi-Tezuka, Y. Fujitani, T. Yamaguchi, K. Nakajima, and T. Hirano. 1996. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: Involvement of STAT3 in anti-apoptosis. Immunity 5: 449-460.
20. L is the major bcl-X mRNA form expressed during mouse development and its product localizes to mitochondria. Development 120: 3033-3040.
21. Grillot, D.A.M., M. González-García, D. Ekhterae, L. Duan, N. Inohara, S. Ohta, M.F. Seldin, and G. Nuñez. 1997. Genomic organization, promoter region analysis and chromosomal localization of the mouse bcl-X gene. J. Immunol. 158: 4750-4757.
22. Haldar, S., N. Jena, and C.M. Croce. 1994. Anti-apoptosis potential of bcl-2 oncogene by dephosphorylation. Biochem. Cell Biol. 72: 455-462.
23. Ihle, J.N. 1995. Cytokine receptor signaling. Nature 377: 591-594.
24. Kinoshita, T., T. Yokota, K. Arai, and A. Miyajima. 1995. Suppression of apoptotic death in hematopoietic cells by signaling through the IL-3/GM-CSF receptors. EMBO J. 14: 266-275.
25. Kozopas, K.M., T. Yang, H.L. Buchan, K.J. Townsend, and R.W. Craig. 1993. MCL-1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL-2. Proc. Natl. Acad. Sci. 90: 3516-3519.
26. Krajewski, S., C. Blomqvist, K. Franssila, M. Krajewska, V.M. Wasenius, E. Niskanen, S. Nordling, and J.C. Reed. 1995. Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res. 55: 4471-4478.
27. Kurtin, P.J., G.W. Dewald, D.J. Shields, and C.A. Hanson. 1996. Haematologic disorders associated with deletions of chromosome 20q - a clinicopathologic study of 107 patients. Am. J. Clin. Path. 106: 680-688.
28. Lacronique, V., A. Boureux, V. Dellavalle, H. Poirel, C.T. Quang, M. Mauchauffe, C. Berthou, M. Lessard, R. Berger, J. Ghysdael, and O.A. Bernard. 1997. A Tel-Jak2 fusion protein with constitutive kinase activity in human leukemia. Science 278: 1309-1312.
29. Leverrier, Y., J. Thomas, G.R. Perkins, M. Mangeney, M.K. Collins, and J. Marvel. 1997. In bone marrow derived Baf-3 cells, inhibition of apoptosis by IL-3 is mediated by two independent pathways. Oncogene 14: 425-430.
30. Lin, E.Y., A. Orlofsky, M.S. Berger, and M.B. Prystowsky. 1993. Characterization of A1, a novel hemopoietic-specific early response gene with sequence similarity to bcl-2. J. Immunol. 151: 1979-1989.
31. L and Mcl-1. Blood 89: 4415-4424.
32. Miura, O., J.L. Cleveland, and J.N. Ihle. 1993. Inactivation of the erythropoietin receptor by point mutations in a region showing homology with other cytokine receptors. Mol. Cell Biol. 13: 1788-1795.
33. Miura, O., N. Nakamura, J.N. Ihle, and N. Aoki. 1994a. Erythropoietin-dependent association of phophatidylinositol 3-kinase with tyrosine-phosphorylated erythropoietin receptor. J. Biol. Chem. 269: 614-620.
34. Miura, Y., O. Miura, J.N. Ihle, and N. Aoki. 1994b. Activation of the mitogen-activated protein kinase pathway by the erythropoietin receptor. J. Biol. Chem. 269: 29962-29969.
35. Miyashita, T. and J.C. Reed. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299.
36. Motoyama, N., F. Wang, K.A. Roth, H. Sawa, K. Nakayama, I. Negshi, S. Senju, Q. Zhang, S. Fujii, and D. Loh. 1995. Massive cell death of immature hematopoietic cells and neurons in bcl-X-deficient mice. Science 267: 1506-1509.
37. Nakamura, N., H. Chin, N. Miyasaka, and O. Miura. 1996. An epidermal growth factor receptor/Jak2 tyrosine kinase domain chimera induces tyrosine phosphorylation of Stat5 and transduces a growth signal in hematopoietic cells. J. Biol. Chem. 271: 19483-19488.
38. Nip, J., D.K. Strom, B.E. Fee, G. Zambetti, J.L. Cleveland, and S.W. Hiebert. 1997. E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis. Mol. Cell Biol. 17: 1049-1056.
39. Nosaka, T., J.M.A. Van Deursen, R.A. Tripp, W.E. Thierfelder, B.A. Witthuhn, A.P. McMickle, P.C. Doherty, G.C. Grosveld, and J.N. Ihle. 1995. Defective lymphoid development in mice lacking Jak3. Science 270: 800-802.
40. Oltvai, Z.N., C.L. Milliman, and S.J. Korsmeyer. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619.
41. Ossina, N.K., A. Cannas, V.C. Powers, P.A. Fitzpatrick, J.D. Knight, J.R. Gilbert, E.M. Shektman, L.D. Tomei, S.R. Umansky, and M.C. Kiefer. 1997. Interferon-γ modulates p53-independent apoptotic pathway and apoptosis related gene expression. J. Biol. Chem. 272: 16351-16357.
42. Packham, G. and J.L. Cleveland. 1994. Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis. Mol. Cell Biol. 9: 5741-5747.
43. Packham, G., M. Brimmell, and J.L. Cleveland. 1997. Two isoforms of Bag-1 are generated by alternative translation initiation codons and contain Bcl-2 and activated steroid hormone receptor binding domains. Biochem. J. 328: 807-813.
44. L is heterogenously expressed by acute myeloblastic leukaemia cells and is associated with autonomous growth in vitro and with P-glycoprotein expression. Leukemia 11: 945-949.
45. Parganas, E., D. Wang, D. Stravopodis, D.J. Topham, J.-C. Marine, S. Teglund, E.F. Vanin, S. Bodner, O.R. Colamonici, J.M. van Deursen, G. Grosveld, and J.N. Ihle. 1998. Jak2 is essential for signaling through a variety of cytokine receptors. Cell 93: 385-395.
46. Pezzella, F., A.G. Tse, J.L. Cordell, K.A. Pulford, K.C. Gatter, and D.Y. Mason. 1990. Expression of the bcl-2 oncogene protein is not specific for the 14:18 translocation. Am. J. Pathol. 157: 225-232.
47. Pierce, J.H., P.P. DiFiore, S.A. Aaronson, M. Potter, J. Pumphrey, A. Scott, and J.N. Ihle. 1985. Neoplastic transformation of mast cells by Abelson-MuLV: Abrogation of IL-3 dependence by a non-autocrine mechanism. Cell 41: 685-693.
48. Quelle, F.W., D. Wang, T. Nosaka, W.E. Thierfelder, D. Stravopodis, Y. Weinstein, and J.N. Ihle. 1996. Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response. Mol. Cell. Biol. 16: 1622-1631.
49. Quelle, F.W., J. Wang, D. Wang, J. Feng, J.L. Cleveland, J.N. Ihle, and G.P. Zambetti. 1998. Cytokine rescue of p53-dependent apoptosis and cell cycle arrest is mediated by distinct Jak kinase signaling pathways. Genes & Dev. 12: 1099-1107.
50. Rampino, N., H. Yamamoto, Y. Ionov, Y. Li, H. Sawai, J.C. Reed, and M. Perucho. 1997. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 275: 967-969.
51. Reed, J.C., Y. Tsujimoto, J.D. Alpers, C.M. Croce, and P.C. Nowell. 1987. Regulation of bcl-2 proto-oncogene expression during normal human lymphocyte proliferation. Science 235: 1295-1299.
52. Sedlak, T.W., Z.N. Oltvai, E. Yang, K. Wang, L.H. Boise, C.B. Thompson, and S.J. Korsmeyer. 1995. Multiple Bcl-2 family member demonstrate selective dimerization with Bax. Proc. Natl. Acad. Sci. 92: 7834-7838.
53. Silva, M., C. Richard, A. Benito, C. Sanz, I. Olalla, and J.L. Fernandez-Luna. 1998. Expression of Bcl-x in erythroid precursors from patients with polycythemia vera. N. Engl. J. Med. 338: 564-571.
54. Songyang, Z., D. Baltimore, L.C. Cantley, D.R. Kaplan, and T.F. Franke. 1997. Interleukin-3-dependent survival by the Akt protein kinase. Proc. Natl. Acad. Sci. 94: 11345-11350.
55. Tsujimoto, Y., J. Gorham, J. Cossman, E. Jaffe, and C.M. Croce. 1985. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 229: 1390-1393.
56. Tu, Y., S. Renner, F. Xu, A. Fleishman, J. Taylor, J. Weisz, R. Vescio, M. Rettig, J. Berenson, S. Krajewski, J.C. Reed, and A. Lichtenstein. 1998. BCL-X expression in multiple myeloma: Possible indicator of chemoresistance. Cancer Res. 58: 256-262.
57. Tuscano, J.M., K.M. Druey, A. Riva, J. Pena, C.B. Thompson, and J.H. Kehrl. 1996. Bcl-X rather than Bcl-2 mediates CD40-dependent centrocyte survival in the germinal center. Blood 88: 1359-1364.
58. Vaux, D.L., S. Cory, and J.M. Adams. 1988. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335: 440-442.
59. Villa, P., S.H. Kaufmann, and W.C. Earnshaw. 1997. Caspases and caspase inhibitors. Trends Biochem. Sci. 22: 388-393.
60. Williams, G.T., C.A. Smith, E. Spooncer, T.M. Dexter, and D.R. Taylor. 1990. Hemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 324: 76-79.
61. Witthuhn, B.A., F.W. Quelle, O. Silvennoinen, T. Yi, B. Tang, O. Miura, and J.N. Ihle. 1993. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74: 227-236.
62. Yang, E. and S.J. Korsmeyer. 1996. Molecular thanatopsis: A discourse on the BCL2 family and cell death. Blood 88: 386-401.
63. Yang, X.-F., G.F. Weber, and H. Cantor. 1997. A novel Bcl-x isoform connected to the T cell receptor regulates apoptosis in T cells. Immunity 7: 629-639.
64. Yao, R. and G.M. Cooper. 1995. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 267: 2003-2006.
65. Yin, C., C.M. Knudson, S.J. Korsmeyer, and T. Van Dyke. 1997. Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 385: 637-640.
66. L. Cell 87: 619-628.
67. Zhan, Q., S. Fan, I. Bae, C. Guillouf, D.A. Liebermann, P.M. O'Connor, and A.J. Fornace, Jr. 1994. Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene 9: 3743-3751.